Quantum BioPharma Ltd. (CSE:QNTM)
Canada · Delayed Price · Currency is CAD 4.000
0.00 (0.00%)
Jul 24, 2026, 11:48 AM EST
Quantum BioPharma Market Cap
Quantum BioPharma has a market cap or net worth of CAD 25.59 million as of July 27, 2026. Its market cap has decreased by -75.96% in one year.
Market Cap
25.59M
Enterprise Value
17.62M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.00
ChartMarket Cap Chart
Since May 29, 2018, Quantum BioPharma's market cap has decreased from 158.35M to 25.59M, a decrease of -83.84%. That is a compound annual growth rate of -20.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 25.59M | -36.43% |
| Dec 31, 2025 | 40.26M | 301.84% |
| Dec 31, 2024 | 10.02M | -78.79% |
| Dec 29, 2023 | 47.25M | 18.00% |
| Dec 30, 2022 | 40.04M | -24.98% |
| Dec 31, 2021 | 53.38M | 39.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Resverlogix | 36.10M |
| Telescope Innovations | 35.55M |
| Sona Nanotech | 35.46M |
| Medicenna Therapeutics | 32.31M |
| Defence Therapeutics | 28.42M |
| Thiogenesis Therapeutics | 27.47M |
| Sharp Therapeutics | 27.37M |
| Lobe Sciences | 25.57M |